BRIGHT Institute and Department of Internal Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Cancer Res. 2011 Nov 1;71(21):6708-17. doi: 10.1158/0008-5472.CAN-11-1472. Epub 2011 Sep 21.
The p19ARF tumor suppressor limits ribosome biogenesis and responds to hyperproliferative signals to activate the p53 checkpoint response. Although its activation of p53 has been well characterized, the role of ARF in restraining nucleolar ribosome production is poorly understood. Here we report the use of a mass spectroscopic analysis to identify protein changes within the nucleoli of Arf-deficient mouse cells. Through this approach, we discovered that ARF limited the nucleolar localization of the RNA helicase DDX5, which promotes the synthesis and maturation of rRNA, ultimately increasing ribosome output and proliferation. ARF inhibited the interaction between DDX5 and nucleophosmin (NPM), preventing association of DDX5 with the rDNA promoter and nuclear pre-ribosomes. In addition, Arf-deficient cells transformed by oncogenic RasV12 were addicted to DDX5, because reduction of DDX5 was sufficient to impair RasV12-driven colony formation in soft agar and tumor growth in mice. Taken together, our findings indicate that DDX5 is a key p53-independent target of the ARF tumor suppressor and is a novel non-oncogene participant in ribosome biogenesis.
p19ARF 肿瘤抑制因子限制核糖体的生物发生,并响应过度增殖的信号,激活 p53 检验点反应。虽然其对 p53 的激活已得到很好的描述,但 ARF 抑制核仁核糖体产生的作用知之甚少。在这里,我们报告了使用质谱分析来鉴定 Arf 缺陷型小鼠细胞核仁内的蛋白质变化。通过这种方法,我们发现 ARF 限制了 RNA 解旋酶 DDX5 的核仁定位,DDX5 促进 rRNA 的合成和成熟,最终增加核糖体的输出和增殖。ARF 抑制了 DDX5 和核仁磷酸蛋白(NPM)之间的相互作用,阻止了 DDX5 与 rDNA 启动子和核前核糖体的结合。此外,由致癌性 RasV12 转化的 Arf 缺陷型细胞对 DDX5 有依赖性,因为降低 DDX5 的表达足以损害 RasV12 驱动的软琼脂集落形成和小鼠肿瘤生长。总之,我们的研究结果表明,DDX5 是 ARF 肿瘤抑制因子的一个关键的 p53 非依赖性靶标,是核糖体生物发生的一个新的非癌基因参与因子。